Long-Acting Injectable Cabotegravir: the Future of HIV PrEP

Publish date:

June 02, 2020

AETC Source

Mountain West AETC

This slide set includes an overview of cabotegravir, and provides updates from the phase III PrEP trial and next steps for long-acting PrEP.

Documents

Long-Acting Cabotegravir: The Future of HIV PrEP

Long-Acting Injectable Cabotegravir: The future of HIV PrEP?

Browse more

Languages

Topic(s)

Antiretroviral Therapy,

Pre-exposure Prophylaxis

Type

Training Materials

Quick survey

What is your primary profession/discipline

Other Non-Clinical Professional

Other Allied Professional

What is your primary functional role?

Specify Other Role

In what state or territory is your primary worksite?

To what extent have the resources and trainings available through this website increased your knowledge and skills to provide care for people with HIV?

Please indicate if you have used resources and/or trainings from any of the following in the past 12 months.

Select all that apply

Regional AETC Program(s)

National Clinician Consultation Center (NCCC)

National HIV Curriculum (NHC) e-Learning Platform Programs

I am not aware of any of these programs